A Comprehensive Approach for Better Outcomes By integrating GLP-1 therapies with gut health strategies and holistic lifestyle interventions, physicians can tackle metabolic dysfunction comprehensively
doi:10.1016/0014-5793(96)00895-2 294
The practical takeaway: the availability of compounded GLP-1 medications through any telehealth platform can change depending on ongoing FDA rulemaking, shortage designations, and individual compounding pharmacy compliance
A new federal lawsuit alleges that Chemours Washington Works plant in Parkersburg, West Virginia, continues to release dangerous PFAS (forever chemicals) into the Ohio River, despite prior legal battles and regulatory actions
Wegovy contains the same main ingredient as Ozempic, semaglutide, and is FDA-approved for weight loss in people with obesity or who are overweight with at least one weight-related condition
Too often, people wrongly think obesity is the fault of the individual, when in reality some people have a strong genetic predisposition for it, says Aaron Kelly, PhD, codirector of the Center for Pediatric Obesity Medicine at the University of Minnesota Medical School